Huizenga Theodore Alan 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Sep 18, 2024
Insider Transaction Report
Form 4
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Transactions
- Award
Common Stock
2024-09-16+700→ 42,251 total
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.